Hsbc Holdings PLC Myriad Genetics Inc Transaction History

Hsbc Holdings PLC

$168 Billion
Q4 2024

A detailed history of Hsbc Holdings PLC transactions in Myriad Genetics Inc stock. As of the latest transaction made, Hsbc Holdings PLC holds 30,214 shares of MYGN stock, worth $334,166. This represents 0.0% of its overall portfolio holdings.

Number of Shares

30,214

Previous 20,217 49.45%

Holding current value

$334,166

Previous $553,000 25.14%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$13.17 - $27.03 $131,660 - $270,218	9,997 Added 49.45%	30,214 $414,000
Q3 2024 Nov 14, 2024	SELL	$23.97 - $28.6 $191,184 - $228,113	-7,976 Reduced 28.29%	20,217 $553,000
Q2 2024 Aug 12, 2024	BUY	$17.98 - $25.47 $506,910 - $718,075	28,193 New	28,193 $689,000
Q4 2022 Feb 14, 2023	BUY	$14.51 - $20.99 $73,652 - $106,545	5,076 Added 39.54%	17,914 $259,000
Q3 2022 Nov 14, 2022	SELL	$18.21 - $27.88 $168,897 - $258,587	-9,275 Reduced 41.94%	12,838 $255,000
Q2 2022 Aug 11, 2022	SELL	$16.45 - $25.88 $54,679 - $86,025	-3,324 Reduced 13.07%	22,113 $408,000
Q1 2022 May 16, 2022	BUY	$22.67 - $28.01 $576,656 - $712,490	25,437 New	25,437 $648,000
Q3 2021 Nov 12, 2021	SELL	$29.97 - $36.66 $450,239 - $550,743	-15,023 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$25.39 - $32.61 $153,863 - $197,616	6,060 Added 67.61%	15,023 $459,000
Q1 2021 May 14, 2021	SELL	$19.92 - $31.6 $132,985 - $210,961	-6,676 Reduced 42.69%	8,963 $272,000
Q4 2020 Feb 12, 2021	BUY	$12.16 - $19.77 $190,170 - $309,183	15,639 New	15,639 $309,000
Q2 2020 Aug 14, 2020	SELL	$10.69 - $16.49 $117,322 - $180,977	-10,975 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$9.78 - $29.53 $29,965 - $90,479	-3,064 Reduced 21.82%	10,975 $157,000
Q4 2019 Feb 14, 2020	BUY	$20.93 - $35.1 $293,836 - $492,768	14,039 New	14,039 $387,000
Q2 2019 Aug 13, 2019	SELL	$22.67 - $35.0 $184,171 - $284,340	-8,124 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$26.93 - $34.7 $218,779 - $281,902	8,124 New	8,124 $270,000
Q3 2018 Nov 13, 2018	SELL	$37.57 - $50.34 $597,363 - $800,406	-15,900 Closed	0 $0
Q2 2018 Aug 10, 2018	BUY	$27.75 - $40.17 $441,225 - $638,703	15,900 New	15,900 $593,000
Q4 2017 Feb 14, 2018	SELL	$28.45 - $37.14 $198,068 - $258,568	-6,962 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$24.01 - $36.2 $167,157 - $252,024	6,962	6,962 $252,000

Others Institutions Holding MYGN

# of Institutions

227

Shares Held

92M

Call Options Held

297K

Put Options Held

20.7K

View Full List

About MYRIAD GENETICS INC

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $892M
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

More about MYGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Hsbc Holdings PLC with notifications on news.

Account

Hsbc Holdings PLC Myriad Genetics Inc Transaction History